Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Antibiotic Selection00:57

Antibiotic Selection

59.1K
Overview
59.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

969
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
969
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

695
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
695
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

2.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.5K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

836
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
836

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovation, Nontraditional Antibacterial Drugs, and Clinical Utility.

ACS infectious diseases·2021
Same author

Personal View of the Antibiotic Value Proposition.

ACS infectious diseases·2020
Same journal

Antimicrobial Peptides and Biofilms: From Molecular Interactions to Therapeutic Control.

ACS infectious diseases·2026
Same journal

Comparative Phenotypic Screening Identifies Protein Synthesis Inhibitors as Compounds That Enhance Early Acidification of <i>Mycobacterium tuberculosis</i> in Macrophages.

ACS infectious diseases·2026
Same journal

Correction to "<i>Treponema pallidum</i> Flagellin FlaB3 Activates Inflammation and Inhibits Autophagy in HMC3 Cells via the TLR4 Pathway".

ACS infectious diseases·2026
Same journal

Coumarin-Mediated Inhibition of Diadenylate Cyclase Correlates with Impaired Biofilm Formation in <i>Streptococcus mutans</i>.

ACS infectious diseases·2026
Same journal

Plasminogen Recruitment by <i>Staphylococcus aureus</i> SdrC Reveals a Tractable Antivirulence Target.

ACS infectious diseases·2026
Same journal

Suilysin of <i>Streptococcus suis</i> Serotype 2 Drives Astrocyte Pyroptosis via Activation of the ROS/NLRP3/Caspase-1/GSDMD Pathway.

ACS infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K

Antibacterial Drugs: The Last Frontier.

David M Shlaes1

  • 1Stonington, Connecticut 06378, United States.

ACS Infectious Diseases
|June 13, 2020
PubMed
Summary
This summary is machine-generated.

The pipeline for new antibacterial drugs is critically low, threatening public health. Urgent financial incentives and policy changes are needed to encourage development and ensure access to life-saving treatments.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.4K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K

Related Experiment Videos

Last Updated: Dec 18, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.4K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmaceutical Policy

Background:

  • The development pipeline for novel antibacterial drugs is severely deficient, particularly for high-priority medical needs.
  • Large pharmaceutical companies have largely withdrawn from antibacterial research due to insufficient return on investment, leading to plummeting private investment.
  • Small companies are now the primary source of new antibacterial compounds but face significant financial risks, as evidenced by recent bankruptcies.

Purpose of the Study:

  • To highlight the impending crisis in antibacterial drug development.
  • To propose actionable recommendations to revitalize the antibacterial drug pipeline.
  • To advocate for systemic changes to ensure future availability of effective antibiotics.

Main Methods:

  • Analysis of the current state of antibacterial drug development and investment.
  • Identification of key challenges and risks in the field.
  • Formulation of policy recommendations based on expert opinion and market dynamics.

Main Results:

  • A critical lack of antibacterial drugs in the development pipeline.
  • Significant decline in private investment and the withdrawal of major pharmaceutical companies.
  • Increased financial vulnerability of small companies developing antibacterial agents.

Conclusions:

  • Urgent intervention is required to address the antibacterial drug crisis.
  • Recommendations include market entry rewards, transferable exclusivity vouchers, and enhanced public and professional engagement.
  • Policy and regulatory changes are necessary to support timely clinical guideline updates and the integration of new diagnostic capabilities for antibacterial susceptibility testing.